Katz Frailty Syndrom has no Predictive Value in Low-Risk Patients Undergoing Transcatheter Aortic Valve Implantation

Research Article | DOI: https://doi.org/10.31579/2641-0419/227

Katz Frailty Syndrom has no Predictive Value in Low-Risk Patients Undergoing Transcatheter Aortic Valve Implantation

  • Katarzyna Byczkowska 1*
  • Agnieszka Pawlak 1
  • Robert Gil 1

Central Clinical Hospital of the Ministry of Interior and Administration, Woloska 137 Str. 02507 Warsaw, Poland

*Corresponding Author: Katarzyna Byczkowska, Central Clinical Hospital of the Ministry of Interior and Administration, Woloska 137 Str. 02507 Warsaw, Poland

Citation: Katarzyna Byczkowska, Agnieszka Pawlak, Robert Gil. (2021) Katz Frailty Syndrom has no Predictive Value in Low-Risk Patients Undergoing Transcatheter Aortic Valve Implantation Katarzyna Byczkowska, Agnieszka Pawlak, Robert Gilw. J. Clinical Cardiology and Cardiovascular Interventions, 4(16); Doi:10.31579/2641-0419/227

Copyright: © 2021 Katarzyna Byczkowska, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Received: 27 September 2021 | Accepted: 06 October 2021 | Published: 12 October 2021

Keywords: severe aortic stenosis; frailty syndrome; TAVI

Abstract

Background: Aortic stenosis is a disease of the elderly people, with multiple comorbidities and often with the frailty syndrome. Therefore, we decided that frailty as a clinical factor requires precise characterization as it is a valuable supplement to the risk stratification in transcatheter aortic

Valve implantation (TAVI).

Objective: The aim of our study was to evaluate the prognostic value of the Katz frailty scale in patients undergoing TAVI in relation to the risk of mortality assessed with the STS scale. 

Material and methods: The study included 105 patients with severe aortic stenosis (AS) treated with TAVI at the Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior. In our group, the Katz frailty syndrome confirmed in all patients, and 48% in the advanced stage. 

Results: Statistical analysis showed a significant difference between survival and Katz frailty score before TAVI. Analysis using Cox's model confirmed a significant prognostic value for the Katz frailty syndrome before TAVI. Patients with moderate to severe frailty on the Katz score (values ≤ 4) had a 13,68 times higher risk of death per year compared to the group with Katz frailty syndrome ≥ 5. Multivariate regression analysis indicated that Katz frailty score and STS score were prognostically significant factors of cardiovascular death in patients undergoing TAVI. 

Conclusion: The Katz frailty score had a significant prognostic value in the high- and intermediate risk patients. Katz frailty score and STS risk score significantly correlated with the risk of death from cardiovascular causes in frailty patients undergoing TAVI.

Introduction

Aortic stenosis (AS) is the most commonly diagnosed valve disease in the world [1,2]. Pharmacotherapy is associated with a poor prognosis [3] and a mortality rate of 30-50% within 2 years of the onset of clinical symptoms [4-6]. AS is a disease of the elderly, with multiple comorbidities and often the frailty syndrome. Approximately 30% of patients are disqualified from cardiac surgery [7,8].Classic risk scores have been developed to predict mortality and periprocedural complications in patients undergoing cardiac surgery [9-12]. However, they do not include factors such as cognitive decline and difficulties in independent daily activity, and have limitations in predicting mortality in the population of patients undergoing transcatheter aortic valve implantation (TAVI). Several studies have shown that frailty is associated with higher morbidity and all-causes mortality in patients undergoing cardiac surgery or TAVI [13-17]. In our group, the frailty syndrome concerned all patients, and 48% in the advanced stage. Therefore, we decided that frailty as a clinical factor requires precise characterization as it may be a valuable supplement to the risk stratification of TAVI. So far, it has not been possible to establish one universally accepted scale of frailty syndrome that would be the reference for better prognosis in patients undergoing TAVI.

Objective

The aim of our study was to evaluate the prognostic value of the Katz frailty scale in patients undergoing TAVI in relation to the risk of mortality assessed with the STS scale.

Material and methods

Study populationThe study included 105 patients with severe aortic stenosis (mean age 82,36±4,5; 46% men) and the Katz frailty syndrome treated with TAVI in the Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior and Administration. Inclusion criterion was severe high gradient aortic stenosis treated with TAVI.  Severe AS was diagnosed on the transthoracic echocardiography and determined by the following parameters: AVA <1> 40 mmHg. The decision on qualifying patients for TAVI, vascular access and the type of valve was made by an interdisciplinary heart team. All patients underwent laboratory tests, ECG, echocardiography and was assessed based on the STS scale and the Katz frailty scale (Table I) (11). 

Table I: Katz frailty scale

We were used five types of bioprothesis - Medtronic CoreValve 43,8% (n=46), Medtronic Evolut R 31,4% (n=33), Edwards Sapien 7,6% (n=8), Symetis Accurate 13,3% (n=14), and St. Jude Medical Portico 3,8% (n=4). The following access were used: transfemoral in 88,6% (n = 93) patients, trans-apical in 6,7% (n = 7), trans-aortic in 1,9% (n = 2) and trans-clavicular in 2,9% (n = 3). Follow-up observations were carried out at 1 month and 1 year.

Statistical analysis

In order to assess the normality of a change in the application of the Shapiro-Wilk test. In the absence of normal use, the Mann-Whitney test. In the study mode of the Kaplan-Meier method of survival, and the survival functions were compared using the log-rank test. The Cox hazards model was used as a multi-feature condition that is important to indicate which variables are significant factors influencing survival. To assess the influence of the investigated explanatory possibilities on the dichotomous variable, one-dimensional and multi-dimensional logistic regression were used. The critical significance level (α) for all tests was 0.05 (α = 0,05). Statistical analysis was performed with the use of Statistica v.12.5 (StatSoft).

Results

General characteristics of the studied population

The mean STS score was 7,03 ± 4,24% (STS ≥ 8% – 23,6% of patients, STS 4-8% - 40%, STS ≤ 4% - 36,4%). The Katz frailty syndrome, grade ≤ 4, was found in 44,8% of patients. The clinical characteristics of patients qualified for the TAVI procedure are presented in Table II.

Table II: Basic clinical characteristic patients undergoing TAVI 

Katz frailty syndrome

Mild or moderate and severe frailty in the Katz scale was observed in patients in 55,2% or 44,8%, respectively (Table III). The greatest reduction in the number of patients with Katz frailty score ≤ 4 was observed in the high-risk patients (p ≤ 0,05) after 1-month follow-up and in the intermediate- and high-risk patients after 1-year follow-up (p ≤ 0,05, p ≤ 0,05 respectively). These relations were not observed in low-risk patients (p > 0,05) (Table III).

In the study population, a significant reduction in the symptoms of the Katz frailty syndrome was observed in 1-month (p ≤ 0,05) and 1-year follow-up after TAVI (p ≤ 0,05) compared to the output. There were no significant changes (p > 0,05) between 1-month and 1-year follow-up (Figure 1).Table III: Clinical characteristics depending on the stage of the Katz frailty score.
Figure 1: Change in the stage of Katz frailty score over time.
  1. Katz frailty syndrome and the risk of all-causes mortality after TAVI

There was a statistically significant difference between survival and the Katz frailty syndrome assessed before TAVI (log-rank test, p = 0,0008) (Figure 2). The median survival time was 817 days (Q1, Q3: 408 days, 1,229 days) in patients with Katz scores ≤ 4 and 867 days (Q1, Q3: 389 days, 1,249 days) in patients with Katz scores ≥ 5. 1-year mortality of patients with moderate and severe Katz frailty syndrome was 30%, and with mild Katz frailty syndrome was 3% (p ≤ 0,001).

Figure 2: Kaplan-Meier survival probability due to Katz frailty score.

One-month and 1-year all-causes mortality after TAVI in high- and intermediate-risk patients was a significantly dependent on Katz frailty score (p ≤ 0,05, p ≤ 0,05 respectively). There was no significant change (p > 0,05) in the low-risk patients (Table III).

The Cox proportional hazard model confirmed a significant prognostic value for the Katz frailty syndrome prior to TAVI (p ≤ 0.05). Patients with moderate to severe frailty (values ​​≤ 4) had a 13,68 times higher risk of death (Table IV).

Table IV: Logistic regression analysis for 1 year all-causes mortality after TAVI
  1. 1-year mortality from cardiovascular causes after TAVI and the Katz frailty syndrome

The multivariate logistic regression model indicated the Katz frailty syndrome and the STS risk score before TAVI were prognostically significant factors of cardiovascular death in patients undergoing TAVI (p ≤ 0,01). Patients with moderate and severe Katz frailty syndrome (values ​​≤ 4) had a risk of cardiovascular death 3,28 times higher than those with Katz frailty scores ≥ 5 (p > 0,05). When switching the surgical STS risk category before TAVI from low to intermediate, the risk of death from cardiovascular causes increased 4,60 times, while if the surgical STS risk category was changed from intermediate to high, the risk of death from cardiovascular causes was higher 21,16 times (p ≤ 0,05) after TAVI (Table V).

Table V: Logistic regression analysis for 1-year cardiovascular mortality after TAVI

Discussion

The optimal selection of patients with severe aortic stenosis for the TAVI procedure, taking into the frailty syndrome, remains the subject of many studies and analyzes [5-8,11–14,16]. Our study shows that the stage of Katz frailty syndrome is an important parameter in the assessment of patients before TAVI and has a prognostic value in assessing the risk of death after TAVI, also in depending on the risk in STS score. Our analysis indicate that the Katz frailty score had a significant prognostic value, especially in intermediate- and high risk patients, but no in low-risk patients. Moreover, together with the STS risk scale predicts the risk of death from cardiovascular causes after TAVI.Our data confirm that the Katz frailty syndrome is a significant indicator of mortality in patients after TAVI and these data are consistent with the results presented in previous publications and meta-analysis [11,13-16,18-20]. At the same time, we showed that 1-year all-causes mortality after TAVI in high-risk and intermediate-risk patients was a significantly dependent on Katz frailty score. 

In recently published studies, survival after TAVI was significantly associated with the advancement of the Katz frailty syndrome, and the frailty turned out to be an independent predictor of mortality [20-26]. Moreover, in a study by Rogers et al. it was shown that the frailty syndrome, both independently and by adding it to the risk assessment on the classic STS scale, predicted an all-causes 30-days and one-year mortality after TAVI [9].

There are single studies analyzed the effect of the frailty syndrome on cardiovascular mortality after TAVI. In the Li et al. study, the assessed of geriatric parameters, including the Katz frailty scale, were significantly associated with all-causes and cardiovascular mortality one year after TAVI [18]. Frailty was one of the most important predictors of all-causes mortality, but also of myocardial infarction and stroke in a 9-month follow-up. In our study, we showed that patients with severe SA and the stage of Katz frailty scale ≤ 4 show significantly higher cardiovascular mortality in one-year follow-up after TAVI. Additionally, multivariate regression analysis indicated that the model of the Katz frailty score and the STS risk scores was a prognostic factor of cardiovascular death in frailty patients undergoing TAVI (p ≤ 0,01).

The use of the Katz frailty scale before TAVI to assess high-risk patients in the STS risk scale allows us to further refine the prognosis of patients undergoing TAVI. This has been demonstrated in the above-cited works as well as in the present publication. Interestingly, the Katz frailty scale allows us to differentiate the prognosis of patients with moderate risk in the STS risk score, reaching statistical significance in 1 year follow-up (p≤ 0,05). In contrast, patients with low risk of STS scale showed no differences in prognosis depending on the Katz frailty scale. In low-risk patients in our study, regardless of the Katz frailty scale, no deaths were observed either in one-month or one-year follow-up. Other researchers, such as Bo et al. also showed the best prognosis of patients with low risk of STS scale, and the Katz score ≤ 4 did not differentiate the prognosis despite the fact that deaths were reported in this group (3% vs. 0% and 4% vs. 0%, respectively) [27].

 Frailty syndrome may be a consequence of severe SA, but also severe SA seems to exacerbate the symptoms of frailty. We observed a statistically significant reduction in the symptoms of the Katz frailty syndrome in a 30-day and one-year observation (Figure 1). Our data indicate the possibility of interrupting the progressive impairment of mobility and loss of independence in elderly patients, which may have a significant impact on improving the quality of life in TAVI population of patients. 

Our study complements the growing amounts of evidence supporting the need to assess the frailty syndrome in patients undergoing TAVI. However, in future post-TAVI mortality prediction tools, a standardized assessment of the frailty scores should be largely considered. 

Limitations

Limitations

The strength of our study is assessment of the relationship of the Katz frailty syndrome with the classical STS risk score and their impact on the clinical results after TAVI. However, there are a few limitations to consider. First, we had a small population. Second, the observation time was relatively short. Third, in the study population, different types of bioprotheses were used during TAVI procedure, which may affect the results obtained.

Conclusions

The stage of the Katz frailty syndrome turned out to be significantly associated with one-year mortality after TAVI, both all-causes and cardiovascular. The demonstrated reduction in the number of patients with moderate and severe frailty syndrome, as well as the reduction of the symptoms of the frailty syndrome indicate the possibility of interrupting the progressive limitation of mobility in patients with severe aortic stenosis treated with TAVI. Therefore, the TAVI procedure can be considered an appropriate therapeutic intervention. The predictive value and compliance of the risk stratification at the patient level was significantly improved by considering the simultaneous STS and Katz frailty scores. The Katz frailty score had a significant prognostic value, especially in intermediate- and high-risk patients, but no in low-risk patients. Therefore, estimating the stage of the Katz frailty syndrome before TAVI qualification can`t help stratify risk in low-risk patients.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad